Analysed AQUESTIVE THERAPEUTICS INC (AQST:NASDAQ) News Sources
Aquestive Therapeutics Announces Completion of Type A Meeting with FDA for Anaphylm™ (dibutepinephrine) Sublingual Film
30-03-2026
yahoo.com
Aquestive Therapeutics Announces New Role of Lori J. Braender and Appointment of Thomas A. Zalewski as Chief Legal Officer and Chief Compliance Officer
20-03-2026
yahoo.com
Aquestive Therapeutics Targets Q3 Anaphylm Resubmission After FDA CRL Flags Human Factors, PK Data
11-03-2026
marketbeat.com
Aquestive Therapeutics Targets Q3 Anaphylm FDA Resubmission After CRL, Details Launch Plans at Leerink Conf
10-03-2026
marketbeat.com
Aquestive Therapeutics Announces Grant of Inducement Award Pursuant to Nasdaq Listing Rule 5635(c)(4)
09-03-2026
yahoo.com
Aquestive Therapeutics Inc (AQST) Q4 2025 Earnings Call Highlights: Revenue Growth Amidst Legal ...
05-03-2026
yahoo.com
What is the current price of AQUESTIVE THERAPEUTICS INC (AQST:NASDAQ)?
The current price of AQUESTIVE THERAPEUTICS INC (AQST:NASDAQ) is $4.34.
AQUESTIVE THERAPEUTICS INC (AQST:NASDAQ) absolute price change since previous trading day?
The absolute price change of AQUESTIVE THERAPEUTICS INC (AQST:NASDAQ) since the previous trading day is $0.1.
AQUESTIVE THERAPEUTICS INC (AQST:NASDAQ) percentage price change since previous trading day?
The percentage price change of AQUESTIVE THERAPEUTICS INC (AQST:NASDAQ) since the previous trading day is 2.3585%.
What is the most recent average sentiment score for AQUESTIVE THERAPEUTICS INC (AQST:NASDAQ)?
The most recent average sentiment score for AQUESTIVE THERAPEUTICS INC (AQST:NASDAQ) is 82 out of 100.
What is the most recent average sentiment for AQUESTIVE THERAPEUTICS INC (AQST:NASDAQ)?
The most recent sentiment for AQUESTIVE THERAPEUTICS INC (AQST:NASDAQ) is .
SEC-8K** Filing Available For AQUESTIVE THERAPEUTICS INC (AQST:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.